Key Insights

Highlights

Success Rate

64% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.0%

5 terminated out of 71 trials

Success Rate

64.3%

-22.2% vs benchmark

Late-Stage Pipeline

13%

9 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results64% success

Data Visualizations

Phase Distribution

43Total
Not Applicable (25)
P 1 (1)
P 2 (8)
P 3 (3)
P 4 (6)

Trial Status

Recruiting21
Unknown21
Not Yet Recruiting12
Completed9
Terminated5
Active Not Recruiting2

Trial Success Rate

64.3%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (71)

Showing 20 of 20 trials
NCT06416371RecruitingPrimary

Retinal Vessel Leakage in Cerebral Small Vessel Disease

NCT07444047Not Yet Recruiting

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

NCT05473637RecruitingPrimary

Taiwan Associated Genetic and Nongenetic Small Vessel Disease

NCT07342075RecruitingPrimary

Registry Study of Cerebral Small Vessel Disease

NCT07271732Not ApplicableNot Yet Recruiting

Songling Xuemaikang Capsules for Cerebral Small Vessel Disease

NCT07252544Phase 3Not Yet Recruiting

Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)

NCT07200921Phase 2Not Yet Recruiting

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills

NCT06579664Not ApplicableRecruitingPrimary

Intermittent Theta Burst Stimulation on Cognitive Impairment of Cerebral Small Vessel Disease

NCT04753970Phase 1RecruitingPrimary

Retina is a Marker for Cerebrovascular Heath

NCT06999668Not ApplicableNot Yet Recruiting

Prospective Randomized Controlled Trial of VR Cognitive Training in Reducing Postoperative Delirium in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery

NCT06164262RecruitingPrimary

Dementia Risk Registry for Young and Middle-aged CSVD Patients in the Next 10 Years

NCT06010511RecruitingPrimary

WHIte MAtter Hyperintensity Shape and Glymphatics

NCT06031610Recruiting

Revascularization Effect on CSVD Burden in Carotid Artery Stenosis

NCT06579677Recruiting

PRospective Observation on CErebral microvaScular Structure and Function

NCT05967728Phase 2Enrolling By InvitationPrimary

Testing of a System for Remote Ischemic Conditioning in Cerebral Small Vessel Disease and Pre-hospital Stroke Care

NCT05173896Phase 2Active Not RecruitingPrimary

Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial

NCT03451591Phase 2CompletedPrimary

LACunar Intervention (LACI-2) Trial-2

NCT06474507Not ApplicableRecruiting

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)

NCT06176404Not ApplicableCompleted

Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

NCT06512376Active Not RecruitingPrimary

Hereditary Cerebral Small Vessel Diseases Registry-Trial Ready Cohort

Scroll to load more

Research Network

Activity Timeline